Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0IC8U
|
|||
Former ID |
DNC006884
|
|||
Drug Name |
1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea
|
|||
Synonyms |
CHEMBL215168; 1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea; SCHEMBL5144236; MolPort-028-759-082; BDBM100355; BDBM50191872; ZINC36330629; AKOS034496458; MCULE-1016100156; US8501783, 1155; 1-(adamantan-1-yl)-3-(1-propylpiperidin-4-yl)urea; Z642063290
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H33N3O
|
|||
Canonical SMILES |
CCCN1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
|
|||
InChI |
1S/C19H33N3O/c1-2-5-22-6-3-17(4-7-22)20-18(23)21-19-11-14-8-15(12-19)10-16(9-14)13-19/h14-17H,2-13H2,1H3,(H2,20,21,23)
|
|||
InChIKey |
OYDLKUZQSIKGSE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Peroxisome | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Metapathway biotransformation | |||
Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
Arachidonic acid metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.